Adam E. Handel

Adam E. Handel

Auto-generated profile, based on publicly available information

Adam E. Handel

Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford , Oxford, OX3 9DU

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 August 2010 in Genome Research
Verified
Journal Article
Closed access
PDF file
SRSreeram V. Ramagopalan
Sreeram V. Ramagopalan
AHAndreas Heger
Andreas Heger
ABAntonio J. Berlanga
Antonio J. Berlanga
NMNarelle J. Maugeri
Narelle J. Maugeri
MLMatthew R. Lincoln
Matthew R. Lincoln
JKJulian C. Knight
Julian C. Knight
Initially thought to play a restricted role in calcium homeostasis, the pleiotropic actions of vitamin D in biology and their clinical significance are only now becoming apparent. However, the mode of action of vitamin D, through its cognate nuclear vitamin D receptor (VDR), and its contribution to diverse disorders, remain poorly understood. We determined VDR binding throughout the human genome using chromatin immunoprecipitation followed by massively parallel DNA sequencing (ChIP-seq). After calcitriol stimulation, we identified 2776 genomic positions occupied by the VDR and 229 genes with significant changes in expression in response to vitamin D. VDR binding sites were significantly enriched near autoimmune and cancer associated genes identified from genome-wide association (GWA) studies. Notable genes with VDR binding included IRF8, associated with MS, and PTPN2 associated with Crohn's disease and T1D. Furthermore, a number of single nucleotide polymorphism associations from GWA were located directly within VDR binding intervals, for example, rs13385731 associated with SLE and rs947474 associated with T1D. We also observed significant enrichment of VDR intervals within regions of positive selection among individuals of Asian and European descent. ChIP-seq determination of transcription factor binding, in combination with GWA data, provides a powerful approach to further understanding the molecular bases of complex diseases.

10 January 2011 in BMC Medicine
Verified
Journal Article
Open access
PDF file
SRSreeram V Ramagopalan
Sreeram V Ramagopalan
CWClare J Wotton
Clare J Wotton
AHAdam E Handel
Adam E Handel
DYDavid Yeates
David Yeates
MGMichael J Goldacre
Michael J Goldacre
Background: Venous thromboembolism (VTE) is a common complication during and after a hospital admission. Although it is mainly considered a complication of surgery, it often occurs in people who have not undergone surgery, with recent evidence suggesting that immune-mediated diseases may play a role in VTE risk. We, therefore, decided to study the risk of deep vein thrombosis (DVT) and pulmonary embolism (PE) in people admitted to hospital with a range of immune-mediated diseases.Methods: We analysed databases of linked statistical records of hospital admissions and death certificates for the Oxford Record Linkage Study area (ORLS1:1968 to 1998 and ORLS2:1999 to 2008) and the whole of England (1999 to 2008). Rate ratios for VTE were determined, comparing immune-mediated disease cohorts with comparison cohorts.Results: Significantly elevated risks of VTE were found, in all three populations studied, in people with a hospital record of admission for autoimmune haemolytic anaemia, chronic active hepatitis, dermatomyositis/polymyositis, type 1 diabetes mellitus, multiple sclerosis, myasthenia gravis, myxoedema, pemphigus/pemphigoid, polyarteritis nodosa, psoriasis, rheumatoid arthritis, Sjogren's syndrome, and systemic lupus erythematosus. Rate ratios were considerably higher for some of these diseases than others: for example, for systemic lupus erythematosus the rate ratios were 3.61 (2.36 to 5.31) in the ORLS1 population, 4.60 (3.19 to 6.43) in ORLS2 and 3.71 (3.43 to 4.02) in the England dataset.Conclusions: People admitted to hospital with immune-mediated diseases may be at an increased risk of subsequent VTE. Our findings need independent confirmation or refutation; but, if confirmed, there may be a role for thromboprophylaxis in some patients with these diseases.

1 September 2010 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AHAdam E. Handel
Adam E. Handel
AWAlexander J. Williamson
Alexander J. Williamson
GDGiulio Disanto
Giulio Disanto
LHLahiru Handunnetthi
Lahiru Handunnetthi
GGGavin Giovannoni
Gavin Giovannoni
SRSreeram V. Ramagopalan
Sreeram V. Ramagopalan
Multiple sclerosis (MS) appears to develop in genetically susceptible individuals as a result of environmental exposures. Epstein-Barr virus (EBV) infection is an almost universal finding among individuals with MS. Symptomatic EBV infection as manifested by infectious mononucleosis (IM) has been shown in a previous meta-analysis to be associated with the risk of MS, however a number of much larger studies have since been published. We performed a Medline search to identify articles published since the original meta-analysis investigating MS risk following IM. A total of 18 articles were included in this study, including 19390 MS patients and 16007 controls. We calculated the relative risk of MS following IM using a generic inverse variance with random effects model. This showed that the risk of MS was strongly associated with IM (relative risk (RR) 2.17; 95% confidence interval 1.97–2.39; p<10−54). Our results establish firmly that a history of infectious mononucleosis significantly increases the risk of multiple sclerosis. Future work should focus on the mechanism of this association and interaction with other risk factors.

25 November 2011 in Annals of Neurology
Verified
Journal Article
Closed access
PDF file
SRSreeram V. Ramagopalan
Sreeram V. Ramagopalan
DDDavid A. Dyment
David A. Dyment
ZCZameel Cader
Zameel Cader
KMKatie M. Morrison
Katie M. Morrison
GDGiulio Disanto
Giulio Disanto
GEGeorge C. Ebers
George C. Ebers

16 February 2010 in Nature Reviews Neurology
Verified
Journal Article
Closed access
AHAdam E. Handel
Adam E. Handel
GGGavin Giovannoni
Gavin Giovannoni
GEGeorge C. Ebers
George C. Ebers
SRSreeram V. Ramagopalan
Sreeram V. Ramagopalan

25 August 2020 in eLife
Verified
Journal Article
Open access
JBJeanette Baran-Gale
Jeanette Baran-Gale
MMMichael D Morgan
Michael D Morgan
SMStefano Maio
Stefano Maio
FDFatima Dhalla
Fatima Dhalla
ICIrene Calvo-Asensio
Irene Calvo-Asensio
GHGeorg A Holländer
Georg A Holländer
Ageing is characterised by cellular senescence, leading to imbalanced tissue maintenance, cell death and compromised organ function. This is first observed in the thymus, the primary lymphoid organ that generates and selects T cells. However, the molecular and cellular mechanisms underpinning these ageing processes remain unclear. Here, we show that mouse ageing leads to less efficient T cell selection, decreased self-antigen representation and increased T cell receptor repertoire diversity. Using a combination of single-cell RNA-seq and lineage-tracing, we find that progenitor cells are the principal targets of ageing, whereas the function of individual mature thymic epithelial cells is compromised only modestly. Specifically, an early-life precursor cell population, retained in the mouse cortex postnatally, is virtually extinguished at puberty. Concomitantly, a medullary precursor cell quiesces, thereby impairing maintenance of the medullary epithelium. Thus, ageing disrupts thymic progenitor differentiation and impairs the core immunological functions of the thymus.